Global Rheumatoid Arthritis Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR012511323

Publication Date:

January 28, 2025

Pages:

106

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Rheumatoid Arthritis Testing market size was valued at US$ 2616 million in 2024 and is forecast to a readjusted size of USD 4180 million by 2031 with a CAGR of 6.9% during review period.
Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.
The rheumatoid arthritis (RA) testing market is experiencing growth, mainly due to the increase in the number of RA patients worldwide, the need for early diagnosis, and the continuous advancement of diagnostic technology. The main drivers of the market include technological advancement, the increase in the elderly population, the need for effective treatment options, and favorable health reimbursement policies. However, market growth also faces some challenges, such as test-related complications, the number of undiagnosed patients, and distrust of certain testing measures.
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.
In addition, the RA treatment market is also showing a trend of diversified development, including the development of biological drugs and targeted therapies, which provide better efficacy and safety by precisely targeting specific immune system components and inflammatory pathways. However, safety issues related to RA treatment may hinder patient acceptance and limit market growth.
Overall, both the RA detection and treatment markets face huge growth potential, but also need to overcome some challenges, such as improving the reliability of detection, reducing costs, raising public awareness of RA, and ensuring the safety and effectiveness of treatment.
This report is a detailed and comprehensive analysis for global Rheumatoid Arthritis Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rheumatoid Arthritis Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Rheumatoid Arthritis Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Rheumatoid Arthritis Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Rheumatoid Arthritis Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rheumatoid Arthritis Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rheumatoid Arthritis Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, Augurex Life Sciences, Svar Life Science AB, Aviva Systems Biology, Bio-Rad Laboratories, Thermo Fisher Scientific, Microdrop, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Rheumatoid Arthritis Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Others
Market segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
Market segment by players, this report covers
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Randox Laboratories
Guangzhou Leide Biosciences
Beijing Diagreat Biotechnologies
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Rheumatoid Arthritis Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Rheumatoid Arthritis Testing, with revenue, gross margin, and global market share of Rheumatoid Arthritis Testing from 2020 to 2025.
Chapter 3, the Rheumatoid Arthritis Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Rheumatoid Arthritis Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rheumatoid Arthritis Testing.
Chapter 13, to describe Rheumatoid Arthritis Testing research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Rheumatoid Arthritis Testing by Type
1.3.1 Overview: Global Rheumatoid Arthritis Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Rheumatoid Arthritis Testing Consumption Value Market Share by Type in 2024
1.3.3 Serological Tests
1.3.4 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
1.3.5 Imaging Tests
1.3.6 Others
1.4 Global Rheumatoid Arthritis Testing Market by Application
1.4.1 Overview: Global Rheumatoid Arthritis Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Clinics
1.4.3 Diagnostic Centers
1.4.4 Others
1.5 Global Rheumatoid Arthritis Testing Market Size & Forecast
1.6 Global Rheumatoid Arthritis Testing Market Size and Forecast by Region
1.6.1 Global Rheumatoid Arthritis Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Rheumatoid Arthritis Testing Market Size by Region, (2020-2031)
1.6.3 North America Rheumatoid Arthritis Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Rheumatoid Arthritis Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Rheumatoid Arthritis Testing Market Size and Prospect (2020-2031)
1.6.6 South America Rheumatoid Arthritis Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Rheumatoid Arthritis Testing Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Product and Solutions
2.1.4 Abbott Laboratories Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Product and Solutions
2.2.4 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 Beckman Coulter
2.3.1 Beckman Coulter Details
2.3.2 Beckman Coulter Major Business
2.3.3 Beckman Coulter Rheumatoid Arthritis Testing Product and Solutions
2.3.4 Beckman Coulter Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Beckman Coulter Recent Developments and Future Plans
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business
2.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Product and Solutions
2.4.4 Siemens Healthineers Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Siemens Healthineers Recent Developments and Future Plans
2.5 Augurex Life Sciences
2.5.1 Augurex Life Sciences Details
2.5.2 Augurex Life Sciences Major Business
2.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Product and Solutions
2.5.4 Augurex Life Sciences Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Augurex Life Sciences Recent Developments and Future Plans
2.6 Svar Life Science AB
2.6.1 Svar Life Science AB Details
2.6.2 Svar Life Science AB Major Business
2.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Product and Solutions
2.6.4 Svar Life Science AB Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Svar Life Science AB Recent Developments and Future Plans
2.7 Aviva Systems Biology
2.7.1 Aviva Systems Biology Details
2.7.2 Aviva Systems Biology Major Business
2.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Product and Solutions
2.7.4 Aviva Systems Biology Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Aviva Systems Biology Recent Developments and Future Plans
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business
2.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Product and Solutions
2.8.4 Bio-Rad Laboratories Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Product and Solutions
2.9.4 Thermo Fisher Scientific Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.10 Microdrop
2.10.1 Microdrop Details
2.10.2 Microdrop Major Business
2.10.3 Microdrop Rheumatoid Arthritis Testing Product and Solutions
2.10.4 Microdrop Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Microdrop Recent Developments and Future Plans
2.11 Werfen
2.11.1 Werfen Details
2.11.2 Werfen Major Business
2.11.3 Werfen Rheumatoid Arthritis Testing Product and Solutions
2.11.4 Werfen Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Werfen Recent Developments and Future Plans
2.12 Axis-Shield
2.12.1 Axis-Shield Details
2.12.2 Axis-Shield Major Business
2.12.3 Axis-Shield Rheumatoid Arthritis Testing Product and Solutions
2.12.4 Axis-Shield Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Axis-Shield Recent Developments and Future Plans
2.13 Randox Laboratories
2.13.1 Randox Laboratories Details
2.13.2 Randox Laboratories Major Business
2.13.3 Randox Laboratories Rheumatoid Arthritis Testing Product and Solutions
2.13.4 Randox Laboratories Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Randox Laboratories Recent Developments and Future Plans
2.14 Guangzhou Leide Biosciences
2.14.1 Guangzhou Leide Biosciences Details
2.14.2 Guangzhou Leide Biosciences Major Business
2.14.3 Guangzhou Leide Biosciences Rheumatoid Arthritis Testing Product and Solutions
2.14.4 Guangzhou Leide Biosciences Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Guangzhou Leide Biosciences Recent Developments and Future Plans
2.15 Beijing Diagreat Biotechnologies
2.15.1 Beijing Diagreat Biotechnologies Details
2.15.2 Beijing Diagreat Biotechnologies Major Business
2.15.3 Beijing Diagreat Biotechnologies Rheumatoid Arthritis Testing Product and Solutions
2.15.4 Beijing Diagreat Biotechnologies Rheumatoid Arthritis Testing Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Beijing Diagreat Biotechnologies Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rheumatoid Arthritis Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Rheumatoid Arthritis Testing by Company Revenue
3.2.2 Top 3 Rheumatoid Arthritis Testing Players Market Share in 2024
3.2.3 Top 6 Rheumatoid Arthritis Testing Players Market Share in 2024
3.3 Rheumatoid Arthritis Testing Market: Overall Company Footprint Analysis
3.3.1 Rheumatoid Arthritis Testing Market: Region Footprint
3.3.2 Rheumatoid Arthritis Testing Market: Company Product Type Footprint
3.3.3 Rheumatoid Arthritis Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Rheumatoid Arthritis Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Rheumatoid Arthritis Testing Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Rheumatoid Arthritis Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Rheumatoid Arthritis Testing Market Forecast by Application (2026-2031)
6 North America
6.1 North America Rheumatoid Arthritis Testing Consumption Value by Type (2020-2031)
6.2 North America Rheumatoid Arthritis Testing Market Size by Application (2020-2031)
6.3 North America Rheumatoid Arthritis Testing Market Size by Country
6.3.1 North America Rheumatoid Arthritis Testing Consumption Value by Country (2020-2031)
6.3.2 United States Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Rheumatoid Arthritis Testing Consumption Value by Type (2020-2031)
7.2 Europe Rheumatoid Arthritis Testing Consumption Value by Application (2020-2031)
7.3 Europe Rheumatoid Arthritis Testing Market Size by Country
7.3.1 Europe Rheumatoid Arthritis Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
7.3.3 France Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Rheumatoid Arthritis Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region
8.3.1 Asia-Pacific Rheumatoid Arthritis Testing Consumption Value by Region (2020-2031)
8.3.2 China Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
8.3.5 India Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
9 South America
9.1 South America Rheumatoid Arthritis Testing Consumption Value by Type (2020-2031)
9.2 South America Rheumatoid Arthritis Testing Consumption Value by Application (2020-2031)
9.3 South America Rheumatoid Arthritis Testing Market Size by Country
9.3.1 South America Rheumatoid Arthritis Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Rheumatoid Arthritis Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country
10.3.1 Middle East & Africa Rheumatoid Arthritis Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Rheumatoid Arthritis Testing Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Rheumatoid Arthritis Testing Market Drivers
11.2 Rheumatoid Arthritis Testing Market Restraints
11.3 Rheumatoid Arthritis Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Rheumatoid Arthritis Testing Industry Chain
12.2 Rheumatoid Arthritis Testing Upstream Analysis
12.3 Rheumatoid Arthritis Testing Midstream Analysis
12.4 Rheumatoid Arthritis Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Randox Laboratories
Guangzhou Leide Biosciences
Beijing Diagreat Biotechnologies

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂